Selected article for: "active treatment and administration route"
Author: Francisca Verdugo-Paiva; Ariel Izcovich; Martin Ragusa; Gabriel Rada
Title: Lopinavir/ritonavir f?or the treatment of COVID-19: A living systematic review protocol
  • Document date: 2020_4_17
    • ID: mhi6w4mr_30
    Snippet: The intervention of interest is the combination of lopinavir/ritonavir. We will not restrict our criteria to any dosage, duration, timing or route of administration. The comparison of interest will be placebo (lopinavir/ritonavir plus optimal treatment versus placebo plus optimal treatment) or no treatment (lopinavir/ritonavir plus optimal treatment versus optimal treatment). Trials assessing lopinavir/ritonavir plus other drugs will be eligible .....
    Document: The intervention of interest is the combination of lopinavir/ritonavir. We will not restrict our criteria to any dosage, duration, timing or route of administration. The comparison of interest will be placebo (lopinavir/ritonavir plus optimal treatment versus placebo plus optimal treatment) or no treatment (lopinavir/ritonavir plus optimal treatment versus optimal treatment). Trials assessing lopinavir/ritonavir plus other drugs will be eligible if the cointerventions are identical in both intervention and comparison groups. Trials evaluating lopinavir/ritonavir in combination with other active drugs versus placebo or no treatment will be also included.

    Search related documents:
    Co phrase search for related documents
    • comparison group and lopinavir ritonavir combination: 1
    • comparison group and optimal treatment: 1
    • interest comparison and optimal treatment: 1
    • interest comparison and optimal treatment plus placebo: 1
    • interest comparison and optimal treatment versus optimal treatment: 1
    • interest comparison and plus placebo: 1
    • interest intervention and optimal treatment: 1, 2
    • interest intervention and optimal treatment plus placebo: 1
    • interest intervention and optimal treatment versus optimal treatment: 1
    • interest intervention and plus placebo: 1
    • lopinavir ritonavir combination and plus placebo: 1
    • lopinavir ritonavir combination and treatment include: 1, 2
    • optimal treatment and plus placebo: 1
    • optimal treatment and route timing: 1
    • optimal treatment and treatment include: 1, 2, 3, 4, 5, 6, 7
    • optimal treatment plus placebo and plus placebo: 1
    • optimal treatment versus optimal treatment and plus placebo: 1
    • plus placebo and treatment include: 1
    • route timing and treatment include: 1